Search research articles
Contact Us
Filters
Showing results (191-200 of 224) with videos related to
Page
of 23
Sort By:
Hepatology (Baltimore, Md.)
|
January 27, 1999
Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity?
P Pontisso, G Bellati, M Brunetto, et al.
Cancer Treatment Reviews
|
December 7, 2010
Update on capecitabine alone and in combination regimens in colorectal cancer patients
N Silvestris, E Maiello, F De Vita, et al.
Breast (Edinburgh, Scotland)
|
February 27, 2010
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer
M Venturini, C Bighin, F Puglisi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2007
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
G Gargano, D Calcara, S Corsale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2015
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial
N Normanno, A M Rachiglio, M Lambiase, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2007
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
F De Vita, F Giuliani, M Orditura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 4, 2011
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study
P Vici, M Brandi, F Giotta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2007
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice
V Gebbia, E Maiello, F Giuliani, et al.
British Journal of Cancer
|
March 10, 2011
FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer
F Bertolini, N Malavasi, L Scarabelli, et al.
Cancer Treatment Reviews
|
December 7, 2010
New molecular targets in bone metastases
D Santini, S Galluzzo, A Zoccoli, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 224) with videos related to
Sort By:
Page
of 23
Hepatology (Baltimore, Md.)
|
January 27, 1999
Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity?
P Pontisso, G Bellati, M Brunetto, et al.
Cancer Treatment Reviews
|
December 7, 2010
Update on capecitabine alone and in combination regimens in colorectal cancer patients
N Silvestris, E Maiello, F De Vita, et al.
Breast (Edinburgh, Scotland)
|
February 27, 2010
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer
M Venturini, C Bighin, F Puglisi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2007
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
G Gargano, D Calcara, S Corsale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2015
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial
N Normanno, A M Rachiglio, M Lambiase, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2007
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
F De Vita, F Giuliani, M Orditura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 4, 2011
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study
P Vici, M Brandi, F Giotta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2007
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice
V Gebbia, E Maiello, F Giuliani, et al.
British Journal of Cancer
|
March 10, 2011
FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer
F Bertolini, N Malavasi, L Scarabelli, et al.
Cancer Treatment Reviews
|
December 7, 2010
New molecular targets in bone metastases
D Santini, S Galluzzo, A Zoccoli, et al.
Page
of 23